HIK — Hikma Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapContrarian

Annual balance sheet for Hikma Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	450	292	229	213	243
Net Total Accounts Receivable
Net Total Receivables	876	841	873	973	1,079
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,094	1,999	2,100	2,263	2,643
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,146	1,081	1,141	1,326	1,448
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	4,372	4,471	4,680	5,133	5,671
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,016	1,077	1,339	1,978	1,453
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,919	2,336	2,482	2,823	3,078
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2,453	2,135	2,198	2,310	2,593
Total Liabilities & Shareholders' Equity	4,372	4,471	4,680	5,133	5,671
Total Common Shares Outstanding